|Year : 2017 | Volume
| Issue : 3 | Page : 171-173
Cardiovascular comorbidities of rheumatoid arthritis in Taiwanese adults: A retrospective single-center study
Ning-Sheng Lai1, Chun-Lung Wang2, Ming-Chi Lu1, Malcolm Koo3
1 Division of Allergy, Immunology and Rheumatology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Dalin, Chiayi; School of Medicine, Tzu Chi University, Hualien, Taiwan
2 Division of Pediatrics, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Dalin, Chiayi, Taiwan
3 Department of Medical Research, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Dalin, Chiayi, Taiwan; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
|Date of Submission||06-Dec-2016|
|Date of Decision||07-Feb-2017|
|Date of Acceptance||12-May-2017|
|Date of Web Publication||14-Sep-2017|
Department of Medical Research, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 2, Minsheng Road, Dalin, Chiayi, Taiwan
Source of Support: None, Conflict of Interest: None
Objective: To evaluate the association between rheumatoid arthritis (RA) and cardiovascular comorbidities, including hyperlipidemia, hypertension, and diabetes, in Taiwanese patients based on the data from medical records. Materials and Methods: A retrospective study was performed using the computerized medical records from a regional hospital located in southern Taiwan. A total of 2293 patients (age range 30–79 years) with a diagnosis of RA (International Classification of Diseases, Ninth Revision, Clinical Modification code 714.0) treated since the opening of the study hospital in July 2000 until February 2013 were included. The RA cases were frequency matched for age and sex with 9172 patients without RA. The associations of RA with hyperlipidemia, hypertension, and diabetes were evaluated using multiple logistic regression analysis. Results: Significant associations between RA and hyperlipidemia (adjusted odds ratio [OR] = 2.05, 95% confidence interval [CI] = 1.77–2.38,P< 0.001) and hypertension (adjusted OR = 2.76, 95% CI = 2.43–3.14,P< 0.001) were observed. However, diabetes was not significantly associated with RA in either male or female patients. Conclusion: Findings from this retrospective medical record study indicated that hyperlipidemia and hypertension were significant cardiovascular comorbidities of RA.
Keywords: Hyperlipidemias, Hypertension, Medical records, Rheumatoid arthritis
|How to cite this article:|
Lai NS, Wang CL, Lu MC, Koo M. Cardiovascular comorbidities of rheumatoid arthritis in Taiwanese adults: A retrospective single-center study. Tzu Chi Med J 2017;29:171-3
|How to cite this URL:|
Lai NS, Wang CL, Lu MC, Koo M. Cardiovascular comorbidities of rheumatoid arthritis in Taiwanese adults: A retrospective single-center study. Tzu Chi Med J [serial online] 2017 [cited 2018 Feb 19];29:171-3. Available from: http://www.tcmjmed.com/text.asp?2017/29/3/171/214699
Ning-Sheng Lai, Chun-Lung Wang.
Both authors contributed equally to this work.
| Introduction|| |
Rheumatoid arthritis (RA), the most common type of inflammatory arthritis, is a debilitating disease characterized by joint pain and impaired functionality. An increased risk for cardiovascular disease in patients with RA has been well recognized, and cardiovascular events are important causes of mortality and morbidity in patients with RA . Nevertheless, the association between cardiovascular comorbidities and RA remains elusive. Hypertension appears to be common in patients with RA . However, a meta-analysis of seven studies revealed that the prevalence of hypertension was similar between patients with RA and controls. The prevalence of diabetes mellitus was increased in RA (odds ratio [OR] = 1.74, P = 0.003), but the prevalence of hypercholesterolemia was not significantly different between patients with RA and controls . In fact, there is conflicting evidence on the prevalence of hyperlipidemia in patients with RA. Some studies demonstrated higher levels of cholesterol , whereas others found decreased levels of cholesterol in patients with RA . Findings from the US Nurses' Health Study showed that, although there was a significant 2-fold increase in the risk of myocardial infarction in women with RA compared with those without, the proportion of hypertension (34% vs. 30%), hypercholesteremia (35% vs. 33%), and diabetes (4.7% vs. 4.9%) was similar between these two groups . Other studies have indicated that traditional cardiovascular risk factors are important predictors of atherosclerosis in patients with RA . These studies have mainly focused on the changes of disease risk in patients with RA. However, few studies have investigated the risk of RA in patients with cardiovascular comorbidities. In particular, relatively little is known about these associations in the Taiwanese population. Therefore, the aim of this study was to evaluate the association between RA and cardiovascular comorbidities, including hyperlipidemia, hypertension, and diabetes, in Taiwanese patients based on the data extracted from medical records.
| Materials and Methods|| |
This study used a case–control study design based on data retrieved from computerized medical records in a regional hospital in southern Taiwan. A total of 2293 patients (age range 30–79 years) with a diagnosis of RA (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 714.0) and 9172 patients without RA, frequency matched on 10-year age intervals and sex (a case–control ratio of 1:4), treated since the opening of the study hospital in July 2000 until February 2013, were included. Diagnoses of hypertension (ICD-9-CM codes 401.0, 401.1, 401.9), hyperlipidemia (ICD-9-CM codes 272.0, 272.2, 272.4, 272.9), and diabetes (ICD-9-CM code 250.x) in both the cases and controls were assessed. The associations of RA with hyperlipidemia, hypertension, and diabetes were evaluated using multiple logistic regression analysis adjusted for age. All statistical analyses were conducted using the IBM SPSS statistics software package, version 23.0 (IBM Corp., Armonk, NY, USA).
The study protocol was reviewed and approved by the institutional review board of the Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (no. B10304017).
| Results|| |
Significantly higher proportions of cardiovascular comorbidities, including hyperlipidemia, hypertension, and diabetes, were observed in the patients with RA compared with controls [Table 1]. [Table 2] summarizes the results of the multiple logistic regression analyses of RA in patients with hyperlipidemia, hypertension, and diabetes. RA was significantly associated with hyperlipidemia (adjusted OR = 2.05, P < 0.001) and hypertension (adjusted OR = 2.76, P < 0.001). Both male and female patients showed a similar pattern of association. While diabetes was significantly and inversely associated with RA when both sexes were analyzed together (adjusted OR = 0.83, P = 0.027), it was no longer an independent significant factor when males and females were analyzed separately.
|Table 1: Characteristics of patients with rheumatoid arthritis and frequency-matched controls (n=11,465)|
Click here to view
|Table 2: Multiple logistic regression analyses of the association between cardiovascular comorbidities and rheumatoid arthritis (n=11,465)|
Click here to view
| Discussion|| |
In this retrospective study, RA was significantly associated with hyperlipidemia and hypertension. These findings are consistent with a recent secondary population-based cross-sectional study of a Japanese health insurance database in which the OR of RA for hyperlipidemia was 3.21 (95% confidence interval [CI] = 2.89–3.56) and for hypertension was 3.12 (95% CI = 2.83–3.44) . Another study of a community-based cohort of patients with RA also reported that cardiovascular diseases, including hypertension, were a prevalent comorbid condition (16% of patients) among patients at RA diagnosis . In addition, a study of 1460 recently diagnosed patients with RA in the United Kingdom showed that hypertension was the most common comorbidity at baseline (standardized incidence ratio = 1.61, 95% CI = 1.43–1.79) .
Although it is plausible that chronic low-grade inflammation in patients with diabetes may contribute to the development of RA ,, the results from two large cohort studies did not find evidence of an association between diabetes and RA ,. Our study also did not find a significant association between diabetes and RA. Additional studies are required to elucidate the connection between diabetes and RA.
Findings from this study need to be weighed within the confines of the limitations of our data source. First, variables such as cigarette smoking and family history were not available in our data source. Nevertheless, when the data were analyzed with stratification by sex, similar associations were found in both male and female patients, even though the prevalence of smoking is generally below 5% in females, compared with over 45% in males, in Taiwan . Therefore, the observed significant associations in RA should not be the result of the differences in smoking between male and female patients. In our study, based on the 1445 patients with available data on smoking status, the prevalence of current and ever smoking in males and females was 42.6% and 1.5%, respectively. Second, the data source of this study came from a single hospital, and loss to follow-up as a result of patients switching health-care providers is possible.
| Conclusion|| |
This medical record-based study indicated that hyperlipidemia and hypertension were two cardiovascular comorbidities that were significantly associated with RA. These findings support further evaluation of whether the use of more aggressive blood lipid management strategies can reduce the risk of developing RA.
We thank the staff of the Division of Allergy, Immunology and Rheumatology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, for assisting with the data collection.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Meune C, Touzé E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: A systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009;48:1309-13.
Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1286-98.
Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis. Joint Bone Spine 2011;78:179-83.
Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: Effect of early treatment – A prospective, controlled study. Arthritis Res Ther 2006;8:R82.
Curtis JR, John A, Baser O. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy. Arthritis Care Res (Hoboken) 2012;64:1282-91.
Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
Fan F, Galvin A, Fang L, White DA, Moore XL, Sparrow M, et al. Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease. J Inflamm (Lond) 2014;11:29.
Sakai R, Hirano F, Kihara M, Yokoyama W, Yamazaki H, Harada S, et al. High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. Mod Rheumatol 2016;26:522-8.
Kapetanovic MC, Lindqvist E, Simonsson M, Geborek P, Saxne T, Eberhardt K. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: Lack of association between inflammation and cardiovascular disease. Scand J Rheumatol 2010;39:353-9.
Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford) 2013;52:99-110.
Lu MC, Yan ST, Yin WY, Koo M, Lai NS. Risk of rheumatoid arthritis in patients with type 2 diabetes: A nationwide population-based case–control study. PLoS One 2014;9:e101528.
Wang SL, Chang CH, Hu LY, Tsai SJ, Yang AC, You ZH. Risk of developing depressive disorders following rheumatoid arthritis: A nationwide population-based study. PLoS One 2014;9:e107791.
Simard JF, Mittleman MA. Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol 2007;34:469-73.
Tsai YW, Tsai TI, Yang CL, Kuo KN. Gender differences in smoking behaviors in an Asian population. J Womens Health (Larchmt) 2008;17:971-8.
[Table 1], [Table 2]